Liver resection versus transarterial chemoembolization for the treatment of intermediate‐stage hepatocellular carcinoma

BACKGROUND: The role of transarterial chemoembolization (TACE) as the standard treatment for intermediate‐stage hepatocellular carcinoma (HCC) is being challenged by increasing studies supporting liver resection (LR); but evidence of survival benefits of LR is lacking. We aimed to compare the overal...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Med
Glavni autori: Chen, Shuling, Jin, Huilin, Dai, Zihao, Wei, Mengchao, Xiao, Han, Su, Tianhong, Li, Bin, Liu, Xin, Wang, Yu, Li, Jiaping, Shen, Shunli, Zhou, Qi, Peng, Baogang, Peng, Zhenwei, Peng, Sui
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2019
Teme:
Clinical Cancer Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6488138/
https://ncbi.nlm.nih.gov/pubmed/30864247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2038
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items